表紙
市場調查報告書

自行注射的皮下輸液設備 (可攜式)

Self-Administered Ambulatory Subcutaneous Infusion Systems

出版商 Greystone Research Associates 商品編碼 929359
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
自行注射的皮下輸液設備 (可攜式) Self-Administered Ambulatory Subcutaneous Infusion Systems
出版日期: 2020年03月24日內容資訊: 英文
簡介

自行注射療法的採用與接受度擴大,患者減少花在醫生身上的時間,在治療的實施和管理中發揮很大的作用。醫療提供中這個戲劇性的變化,由於患者友善的設計舉措產生對設備的必要性。

本報告提供自行注射的皮下輸液設備 (可攜式) 調查分析,設備詳細內容,對象市場,課題,需求促進因素,影響等相關的系統性資訊。

目錄

摘要整理

注射劑/投入的藥劑市場區隔趨勢

  • 醫藥品開發趨勢
  • 藥物輸送設備的演進
  • 患者的自行注射的趨勢
  • 實行技術
  • 冷凍乾燥藥/重組

皮下輸液設備 - 設計要素

  • 數量和粘度
  • 一次包裝
  • 注射方法
  • 設備電子產品

皮下注射設備 - 市場區隔

  • 門診病人的注射成本、物流的負擔
  • 生技藥品
  • 大容量藥
  • 期間依賴給藥藥

皮下輸液設備的設備分析

  • enFuse
  • Libertas
  • Evolve
  • SensePatch
  • SmartDose
  • SmartDose Preloaded
  • YpsoDose
  • E3D Patch Pump
  • Pod

市場要素

  • 自行注射和患者配合度
  • 法規的指導與產品的認證
  • 醫療的經濟
  • 製劑的差異化

市場參與企業的簡介

目錄
Product Code: SASJ786K

Converging Factors Driving the Growth of Subcutaneous Infusion

As currently formulated, a significant number of therapeutic drugs require dosage volumes or possess viscosities well in excess of the upper range for traditional subcutaneous delivery. These drugs are currently delivered via infusion. The demographics of patient populations and the current trend in therapeutic drug development are converging to create an increasingly steep demand curve for infusion. The costs and logistics of this convergence are a major driver of the energy behind small form factor subcutaneous infusion systems. As the adoption of and acceptance of self-administered therapies grows, patients are spending less time with physicians and are playing a greater role in the delivery and management of their treatments. This dramatic shift in healthcare delivery is creating a need for devices that mask an underlying layer of complexity via design initiatives that are patient-friendly.

What You Will Learn:

  • What ambulatory subcutaneous infusion systems are currently marketed or in development, who are the suppliers, and what are the device specifics?
  • What are the therapeutic markets being targeted by ambulatory subcutaneous infusion systems?
  • What are the essential design factors, material selection issues, technologies and market development issues for ambulatory subcutaneous infusion systems?
  • What are the major factors that will drive ambulatory subcutaneous infusion systems demand?
  • What is the addressable market for subcutaneous infusion systems?
  • What is the expected impact of subcutaneous infusion systems on drug delivery markets?
  • Who are the significant players in this segment? What are their strategies? Who are their alliance partners?

Table of Contents

Executive Summary

Injectable/Infusible Market Segment Dynamics

  • Drug Development Trends
  • Drug Delivery Device Evolution
  • The Trend toward Patient Self-Administration
  • Enabling Technology
  • Lyophilized Drugs/Reconstitution

Subcutaneous Infusion Systems - Design Factors

  • Volumes and Viscosities
  • Primary Packaging
  • Injection Method
  • Device Electronics

Subcutaneous Infusion Devices - Market Segments

  • The Cost and Logistical Burden of Out-patient Infusion
  • Biologicals
  • High Volume Drugs
  • Duration Dependent Administration Drugs

Subcutaneous Infusion Systems Device Analysis

  • enFuse
  • Libertas
  • Evolve
  • SensePatch
  • SmartDose
  • SmartDose Preloaded
  • Unbranded Device
  • Unbranded Device
  • YpsoDose
  • E3D Patch Pump
  • Pod

Market Factors

  • Self-Administration and Patient Compliance
  • Regulatory Guidance and Product Approvals
  • Healthcare Economics
  • Drug Product Differentiation

Market Participant Profiles